Lineagen delivers more than just a genetic test

Our team helps you every step of the way

Watch video

What is Lineagen's FirstStepDx PLUS®?

FirstStepDx PLUS includes a Chromosomal Microarray (CMA) that can identify an underlying genetic cause in individuals with developmental delay, intellectual disability, and autism spectrum disorder. Lineagen makes genetic testing easy and accessible for everyone. Your patient's sample is collected with a painless, non-invasive cheek swab, and Lineagen handles all of the insurance correspondence followed by delivery of a thorough, yet easy-to-read report.

FirstStepDx PLUS Chromosomal Microarray (CMA) testing service includes:

  • Highest detection rate and widest range of genetic diagnoses for children with developmental delay, including autism spectrum disorder
  • Personalized genetic counseling and clinical support
  • Comprehensive support of the insurance process
  • Detailed clinical report with extensive medical references and an easily understandable, focused report
30pp-graphic

Optimization of the FirstStepDx PLUS CMA results in a 30% detection rate of clinically relevant results, the highest detection rate of any clinically available CMA test.

How can FirstStepDx PLUS help my patients?

FirstStepDx PLUS can detect an underlying genetic cause of developmental delay, which means opening up new treatment options and pointing towards necessary evaluations. A CMA can pinpoint one of hundreds of known conditions that may be responsible for your patient's clinical features, which treatments should be considered, including evaluations for co-occurring medical issues, and recurrence risk for the family.

See benefits
 
Watch video

What makes FirstStepDx PLUS different?

Best-in-class Chromosomal Microarray Genetic Test

FirstStepDx PLUS Chromosomal Microarray (CMA) is optimized with unique detection sites1, 2 to increase detection rate, as well as rule out many other conditions.

  • Additional validated detection sites increase detection rate
  • Highest detection rate (30%) of any clinically available CMA test
  • Rules out hundred of genetic conditions
  • Non-invasive DNA collection produces superior clinical results - improved detection of certain mosaic conditions3

Comprehensive Clinical Support

  • Pre- and post-test genetic counseling
  • Individualized patient reports with a dedicated provider section and an easy-to-read family section
  • Reports include a comprehensive list of relevant literature for optimal result interpretation

Personalized Insurance Assistance

  • Lineagen handles all insurance correspondence, from pre-authorizations to appeals
  • Expert team of insurance specialists
  • Various assistance programs and payment plans and other financial assistance options
icon-quote

Highest
detection rate

icon-quote

Painless
cheek swab

icon-quote

Easy to understand
test results report

Lineagen helps healthcare providers and patients understand their test results.

Our genetic counselors explain the test results in a thorough, but easy-to-understand report. Even if this is your first genetic test, you'll have no trouble understanding the results and advising parents on their options.

The report also includes a section for parents and, if there are any questions, you have unlimited access to our genetic counselors.

View sample report
 
Watch video

Lineagen handles every step of the insurance process for you.

For some healthcare providers, the most challenging part of ordering a genetic test is the long process of authorizations and appeals.

Lineagen takes the insurance burden from providers and their staff by assisting in every step of the process. This way providers can focus on direct patient care.

Take the insurance burden off
 
Watch video
icon-quote
There are hundreds or even thousands of genetic syndromes, many of which have overlapping features, which make it very difficult without the use of genetic testing technology to pinpoint exactly which syndrome a patient may have.
Rena Vanzo
MS, LCGC Licensed & Certified Genetic Counselor,
Vice President, Clinical Services, Lineagen, Inc.
CMA testing should be done at the earliest signs of developmental concern. Waiting can be stressful for these families and harmful for their child, because they can lose months of therapy and physicians can lose months of important treatment time for that child.
Rena Vanzo
MS, LCGC Licensed & Certified Genetic Counselor,
Vice President, Clinical Services, Lineagen, Inc.
We have genetic counselors who are on call, available to answer questions from healthcare providers at any time, even while the patients are there still in the office.
Rena Vanzo
MS, LCGC Licensed & Certified Genetic Counselor,
Vice President, Clinical Services, Lineagen, Inc.
The sole focus today of all our energy and resources is on the assessment of chromosomes from individuals with developmental disabilities, as there is an under-met need
Rena Vanzo
MS, LCGC Licensed & Certified Genetic Counselor,
Vice President, Clinical Services, Lineagen, Inc.
Through the initial pre-authorization, appeals, or any other requests from the insurer, our team is working to expedite the case to get you and your patients answers sooner so the testing can be administered in a timely fashion.
Rena Vanzo
MS, LCGC Licensed & Certified Genetic Counselor,
Vice President, Clinical Services, Lineagen, Inc.